SEC Form 4 · accession 0001493152-17-012235
VBI Vaccines Inc/BC · VBIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sam Chawla
Director
Period of report
Oct 30, 2017
Accepted (ET)
Oct 31, 2017 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000764195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value per shareF1 | Oct 30, 2017 | P | 3,100,000 | $3.05 | A | 9,345,725 | I | See Footnote |
| Common Shares, no par value per share | holding | — | — | — | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held of record by Perceptive Life Sciences Master Fund Ltd.. As a Portfolio Manager of Perceptive Advisors LLC, a related entity to Perceptive Life Sciences Master Fund Ltd., Mr. Chawla may be deemed to have investment control over any securities owned of record by Perceptive Life Sciences Master Fund Ltd. Mr. Chawla disclaims for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Chawla is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.